Table 3.

Anti-tick antigens developed and tested by CSIRO after Bm86 registration.

Antigen Description	Testing Regime	Published Efficacy	References
Bm91/Angiotensin-converting enzyme-like/Carboxypeptidase	Bm86 + Bm91, tested in cattle	7% reduction in egg viability	[48,49,50]
BMA7/Mucin-like glycoprotein	BMA7; Bm86+BMA7, tested in cattle	21% reduction in egg weights; doubled efficacy when mixed with Bm86	[51]
GP80/VIT87 Vitellin/Vitellogenin	Tested in sheep	66–68% reduction in tick larvae (native protein); 0% efficacy (recombinant)	[52]
5′ nucleotidase/Apyrase	5′ nucleotidase; Bm86 + 5′ nucleotidase, tested in sheep and cattle	No efficacy (cattle)	[53]